Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an ...

Wall Street analysts upgraded Stryker Corp (NYSE: SYK) after its Q4 report beat expectations, with strong sales and earnings ...

Stryker reached an agreement with family investment firm Viscogliosi Brothers to sell its U.S. spinal implants business for an undisclosed amount, the companies announced Tuesday. The newly formed ...

Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to ...

Stryker is selling its U.S. spinal implant business to investment firm Viscogliosi Brothers, a move that is expected to help the company ...

Stryker, one of the world’s largest medtech companies, announced on January 28 that it would be selling its Spinal Implants business to ...

Lake Street analyst Brooks O’Neil notes that Stryker (SYK) announced a definitive agreement for the sale of its U.S. spinal implants business ...

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its outlook for 2025.